Innovation Medical(SZ:002173) Xin Lang Cai Jing·2026-02-27 05:30Core Insights - The China Securities Medical and Medical Device Innovation Index (931484) has seen a slight increase of 0.31%, with notable gains from stocks such as Huitai Medical (+6.20%) and Yingke Medical (+4.17%) [1] - The National Medical Products Administration (NMPA) reported that in 2025, it received 457 applications for special approval of innovative medical devices, with 104 approved for special review and 26 out of 38 priority applications granted [1] Group 1: Market Performance - The Medical Innovation ETF (516820) rose by 0.28%, with the latest price at 0.36 yuan [1] - The top ten weighted stocks in the China Securities Medical and Medical Device Innovation Index account for 63.9% of the index, including companies like WuXi AppTec and Mindray Medical [2] Group 2: Investment Strategy - Huafu Securities emphasizes a continued focus on the pharmaceutical technology sector, highlighting three main areas for 2026: revenue and performance realization, unexpected business development outcomes, and cutting-edge technology platforms [2] - In the medical device sector, the focus is on inventory replenishment and bidding for surgical robots and endoscopes, as well as innovative consumables benefiting from centralized procurement [2] - The central economic work conference has indicated a shift towards domestic demand, suggesting that companies related to domestic medical needs may experience a turning point [2]